AngioDynamics Inc (ANGO) - Cash Flow Conversion Efficiency
Based on the latest financial reports, AngioDynamics Inc (ANGO) has a cash flow conversion efficiency ratio of -0.018x as of February 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.11 Million) by net assets ($173.36 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check ANGO PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.
AngioDynamics Inc - Cash Flow Conversion Efficiency Trend (2002–2025)
This chart illustrates how AngioDynamics Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See ANGO total equity for net asset value and shareholders' equity analysis.
AngioDynamics Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of AngioDynamics Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Rieter Holding AG
SW:RIEN
|
-0.005x |
|
S.C. CHIMCOMPLEX S.A.
RO:CRC
|
-0.008x |
|
CNFC Overseas Fishery Co Ltd
SHE:000798
|
0.072x |
|
Alandsbanken Abp B
HE:ALBBV
|
0.054x |
|
Huchems
KO:069260
|
0.030x |
|
Deutsche Beteiligungs AG
XETRA:DBAN
|
-0.020x |
|
Hankook Shell Oil
KO:002960
|
0.124x |
|
Cub Elecparts Inc
TW:2231
|
-0.064x |
Annual Cash Flow Conversion Efficiency for AngioDynamics Inc (2002–2025)
The table below shows the annual cash flow conversion efficiency of AngioDynamics Inc from 2002 to 2025. For the full company profile with market capitalisation and key ratios, see AngioDynamics Inc stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-05-31 | $182.97 Million | $-10.13 Million | -0.055x | +59.59% |
| 2024-05-31 | $205.59 Million | $-28.16 Million | -0.137x | -66527.12% |
| 2023-05-31 | $378.30 Million | $78.00K | 0.000x | +101.22% |
| 2022-05-31 | $424.49 Million | $-7.19 Million | -0.017x | -130.91% |
| 2021-05-31 | $439.46 Million | $24.09 Million | 0.055x | +271.73% |
| 2020-05-31 | $455.87 Million | $-14.55 Million | -0.032x | -152.43% |
| 2019-05-31 | $614.82 Million | $37.44 Million | 0.061x | -19.97% |
| 2018-05-31 | $542.60 Million | $41.29 Million | 0.076x | -29.43% |
| 2017-05-31 | $517.03 Million | $55.74 Million | 0.108x | +20.90% |
| 2016-05-31 | $507.03 Million | $45.22 Million | 0.089x | +89.23% |
| 2015-05-31 | $545.02 Million | $25.68 Million | 0.047x | +2.71% |
| 2014-05-31 | $537.89 Million | $24.68 Million | 0.046x | -9.30% |
| 2013-05-31 | $526.83 Million | $26.65 Million | 0.051x | +128.22% |
| 2012-05-31 | $523.39 Million | $11.60 Million | 0.022x | -73.44% |
| 2011-05-31 | $405.75 Million | $33.87 Million | 0.083x | -18.25% |
| 2010-05-31 | $391.35 Million | $39.96 Million | 0.102x | +90.57% |
| 2009-05-31 | $372.19 Million | $19.94 Million | 0.054x | -26.43% |
| 2008-05-31 | $355.71 Million | $25.91 Million | 0.073x | +178.55% |
| 2007-05-31 | $335.96 Million | $8.78 Million | 0.026x | +0.26% |
| 2006-05-31 | $123.44 Million | $3.22 Million | 0.026x | -73.25% |
| 2005-05-31 | $49.11 Million | $4.79 Million | 0.097x | +45.20% |
| 2004-05-31 | $37.23 Million | $2.50 Million | 0.067x | -85.31% |
| 2003-05-31 | $1.49 Million | $680.00K | 0.457x | +111.18% |
| 2002-05-31 | $-295.00K | $1.21 Million | -4.088x | -- |
About AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall … Read more